MCDERMOTT+ LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues of prescription drug pricing in Medicare and Medicaid. Rebate rule. H.R. 5376 - Build Back Better Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
Pharmacy PHA
S. 1391 - Fair Accountability and Innovative Research Drug Pricing Act. Prescription drug pricing issues. Patent abuse issues. Ensuring Innovation Act and the Advancing Education on Biosimilars Act of 2021. Drug-price Transparency for Competition (DTC) Act. H.R. 5376 - Build Back Better Act. Prescription Drug User Fee Act. H.R. 6833 - Affordable Insulin Now Act. National Coverage Determination on Aduhelm. User Fee bills. Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
Copyright/Patent/Trademark CPT
The Stalling Act. The Affordable Prescriptions for Patients through promoting Competition Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.